Junlebaby Group's Li Fengting: Deepening "Certainty" in the China Market and Embracing New Opportunities in the Health and Wellness Industry

How can AI and technology empower personalized services in the health industry?

Beijing, March 23 (People’s Daily Online) — The China Development High-Level Forum 2026 Annual Conference was held in Beijing from March 22 to 23, with the theme “China in the 14th Five-Year Plan: High-Quality Development and New Opportunities for Innovation.” Jianhe Group CEO Li Fengting stated during the forum that in an uncertain global environment, China provides greater certainty for business development. Moving forward, the company will focus on the Chinese market to deepen high-quality growth and seize new industry opportunities brought by the “Healthy China” initiative under the 14th Five-Year Plan.

During this year’s forum, “Healthy China 2030” and the development of the health industry became hot topics. Li Fengting believes that global companies’ confidence in China’s business environment continues to grow. This confidence stems from the increasing transparency of business rules, the positive continuity of policies, and China’s large market size. Based on this, companies will develop their strategies centered on the Chinese market.

Jianhe Group CEO Li Fengting was invited to participate in the China Development High-Level Forum 2026 Annual Conference. (Photo provided by interviewee)

Regarding the development direction of the health industry during the 14th Five-Year Plan, Li Fengting said that under the guidance of the “Health Priority Development Strategy,” the industry’s positive trend is based on three factors: clearer policy guidance providing direction for regulation, innovation, and scientific research; the “Healthy China” strategy’s focus on elderly care, chronic disease management, and shifting from “treating illness” to “preventing disease,” especially with lifestyle interventions being prioritized, opening broad opportunities for the industry; and China’s leadership in technology-driven and smart applications globally, with AI and other new technologies expected to bring more personalized management solutions to the health sector.

“A very clear trend is that China’s economy is increasingly emphasizing quality development, and health consumption is an important part of high-quality growth,” Li Fengting believes. From the demand side, as demographic changes and health awareness increase, consumers’ focus on nutrition and health has shifted from “basic supplementation” to “refined management” and “long-term health investment,” transforming the health industry from optional consumption to a “rigid demand” with long-term attributes.

From the supply side, technological advances are profoundly changing industry dynamics. New technologies represented by biotechnology, digitalization, and AI not only enhance product research and quality control but also reshape service methods between companies and consumers.

“This aligns with Jianhe’s development plan. We are not just expanding a single product category but continuously building more systematic products and services around family nutrition and health, establishing long-term value in more segmented and professional needs,” Li Fengting explained. Facing new development opportunities, the company’s future strategic focus will be on three directions: first, centering on product solutions, promoting upgrades from single product innovation to biological mechanism-based nutritional interventions in areas like weight management, the silver economy, and age-specific nutrition; second, leveraging AI and other intelligent tools to improve scientific evidence and innovation efficiency, while enhancing safety and quality control; third, advocating for healthy “anti-involution,” guiding consumers back to more natural and authentic lifestyles.